| Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement F Kronenberg, S Mora, ESG Stroes, BA Ference, BJ Arsenault, L Berglund, ... European heart journal 43 (39), 3925-3946, 2022 | 576 | 2022 |
| Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress TA Seimon, MJ Nadolski, X Liao, J Magallon, M Nguyen, NT Feric, ... Cell metabolism 12 (5), 467-482, 2010 | 558 | 2010 |
| Oxidized phospholipids on lipoprotein (a) elicit arterial wall inflammation and an inflammatory monocyte response in humans FM van der Valk, S Bekkering, J Kroon, C Yeang, J Van den Bossche, ... Circulation 134 (8), 611-624, 2016 | 532 | 2016 |
| Use of Lipoprotein (a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association DP Wilson, TA Jacobson, PH Jones, ML Koschinsky, CJ McNeal, ... Journal of clinical lipidology 13 (3), 374-392, 2019 | 482 | 2019 |
| NHLBI working group recommendations to reduce lipoprotein (a)-mediated risk of cardiovascular disease and aortic stenosis S Tsimikas, S Fazio, KC Ferdinand, HN Ginsberg, ML Koschinsky, ... Journal of the American College of Cardiology 71 (2), 177-192, 2018 | 450 | 2018 |
| Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein (a) and Cardiovascular Disease: recent advances and future directions SM Marcovina, ML Koschinsky, JJ Albers, S Skarlatos Clinical chemistry 49 (11), 1785-1796, 2003 | 407 | 2003 |
| Effect of the number of apolipoprotein (a) kringle 4 domains on immunochemical measurements of lipoprotein (a) SM Marcovina, JJ Albers, B Gabel, ML Koschinsky, VP Gaur Clinical chemistry 41 (2), 246-255, 1995 | 402 | 1995 |
| Lipoprotein (a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association G Reyes-Soffer, HN Ginsberg, L Berglund, PB Duell, SP Heffron, ... Arteriosclerosis, Thrombosis, and vascular biology 42 (1), e48-e60, 2022 | 374 | 2022 |
| Lipoprotein (a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis KH Zheng, S Tsimikas, T Pawade, J Kroon, WSA Jenkins, MK Doris, ... Journal of the American College of Cardiology 73 (17), 2150-2162, 2019 | 276 | 2019 |
| Lipoprotein (a) levels and the risk of myocardial infarction among 7 ethnic groups G Paré, A Çaku, M McQueen, SS Anand, E Enas, R Clarke, MB Boffa, ... Circulation 139 (12), 1472-1482, 2019 | 266 | 2019 |
| Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease? MB Boffa, ML Koschinsky Journal of lipid research 57 (5), 745-757, 2016 | 264 | 2016 |
| Identification of the cysteine residue in apolipoprotein (a) that mediates extracellular coupling with apolipoprotein B-100. ML Koschinsky, GP Cote, B Gabel, YY van der Hoek Journal of Biological Chemistry 268 (26), 19819-19825, 1993 | 257 | 1993 |
| Autotaxin derived from lipoprotein (a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve R Bouchareb, A Mahmut, MJ Nsaibia, MC Boulanger, A Dahou, JL Lépine, ... Circulation 132 (8), 677-690, 2015 | 255 | 2015 |
| Lipoprotein (a) as a risk factor for coronary artery disease SM Marcovina, ML Koschinsky The American journal of cardiology 82 (12), 57U-66U, 1998 | 255 | 1998 |
| Structure-function relationships in apolipoprotein (a): insights into lipoprotein (a) assembly and pathogenicity ML Koschinsky, SM Marcovina Current opinion in lipidology 15 (2), 167-174, 2004 | 254 | 2004 |
| Lipoprotein (a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor R Romagnuolo, CA Scipione, MB Boffa, SM Marcovina, NG Seidah, ... Journal of Biological Chemistry 290 (18), 11649-11662, 2015 | 238 | 2015 |
| Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a) 1 G Leibundgut, C Scipione, H Yin, M Schneider, MB Boffa, S Green, ... Journal of lipid research 54 (10), 2815-2830, 2013 | 235 | 2013 |
| Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme M Schneider, M Boffa, R Stewart, M Rahman, M Koschinsky, M Nesheim Journal of Biological Chemistry 277 (2), 1021-1030, 2002 | 233 | 2002 |
| The apolipoprotein (a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms YY Hoek, ME Wittekoek, U Beisiegel, JJP Kastelein, ML Koschinsky Human molecular genetics 2 (4), 361-366, 1993 | 231 | 1993 |
| Lipoprotein (a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models MB Boffa, SM Marcovina, ML Koschinsky Clinical biochemistry 37 (5), 333-343, 2004 | 222 | 2004 |
